The FAM177A1 Research Fund is dedicated to improving the lives of individuals affected by FAM177A1. This rare genetic disorder causes intellectual disability, seizures, autism, arthritis, and other neurodegenerative issues. Currently, there is no cure or treatment available.

Driven by our mission, we are committed to uniting the global FAM177A1 Disorder community and advancing research to develop patient-focused treatments. We collaborate with a distinguished Scientific Advisory Board comprising brilliant scientists, researchers, gene experts, and industry leaders. Together, we are charting a course towards precise treatments for FAM177A1 patients.

Our approach may include drug repurposing, drug development, and gene therapy. Our inspiration comes from Charlotte and Cooper, who were among the first individuals worldwide to be diagnosed with the disease-causing variant on the FAM177A1 gene. We believe that with increased research and support, we can make a significant impact on the lives of FAM177A1 patients and their families.

Join us in our mission to bring hope and improve the future for those affected by FAM177A1. Donations and support are essential in our pursuit of treatments and a cure. Together, we can change lives